Aegerion Pharmaceuticals, Inc.Enters Oversold Territory

Aegerion Pharmaceuticals, Inc.’s (AEGR) share price has entered into oversold territory with a stochastic value of 7.5739. The Zacks Consensus Estimate on the company’s loss for December 2012 decreased by 21 cents over the past two months to $2.29 per share. Aegerion Pharmaceuticals, Inc. is a Zacks #2 Rank (“ Buy”) company.

AEGERION PHARMACEUTICALS INC (AEGR): Free Stock Analysis Report

Zacks Investment Research

• Read the analyst report on AEGR